Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Marina Elena Cazzaniga
Management of Toxicities Associated With Targeted Therapies for HR-positive Metastatic Breast Cancer: A Multidisciplinary Approach Is the Key to Success
Breast Cancer Research and Treatment
Cancer Research
Oncology
Neoadjuvant Eribulin Mesylate Following Anthracycline and Taxane in Triple Negative Breast Cancer: Results From the HOPE Study
PLoS ONE
Multidisciplinary
Related publications
Current Landscape of Targeted Therapies for Hormone-Receptor Positive, HER2 Negative Metastatic Breast Cancer
Frontiers in Oncology
Cancer Research
Oncology
A Changing Natural History of HER2-positive Breast Cancer Metastatic to the Brain in the Era of New, Targeted Therapies
Clinical Breast Cancer
Cancer Research
Oncology
Management of Dermatologic Toxicities Associated With Targeted Therapy
Journal of the Advanced Practitioner in Oncology
New Strategies in Metastatic Hormone Receptor–Positive Breast Cancer: Searching for Biomarkers to Tailor Endocrine and Other Targeted Therapies
Clinical Cancer Research
Cancer Research
Oncology
Breast Cancer: A Multidisciplinary Approach
Journal of Clinical Pathology
Medicine
Forensic Medicine
Pathology
Phase 1b Study of Orteronel in Postmenopausal Women With Hormone-Receptor Positive (HR+) Metastatic Breast Cancer
Investigational New Drugs
Oncology
Pharmacology
Metastatic Triple Negative Breast Cancer: Optimizing Treatment Options, New and Emerging Targeted Therapies
Asia-Pacific Journal of Clinical Oncology
Medicine
Oncology
Targeted Therapy for HER2 Positive Breast Cancer
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Fulvestrant Treatment Is Associated With Cholesterol Plasma Level Reduction in Hormone Receptor-Positive Metastatic Breast Cancer Patients
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
